|
MediciNova Asthma Compound Poised for Late-Stage Trials
San Diego Business Journal By Julie Gallant Tuesday, May 29, 2012 Local biopharmaceutical company MediciNova Inc. received enough positive news from a phase 2b clinical trial evaluating its MN-221 asthma compound to pursue planning for phase 3 trials. |
View full post on asthma – Google News